Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For XPO
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -5.97 0.94 1.00
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA < 0.005 14.07 14.07
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 5.21 11.48 10.91
Cash -44.17 1.98 3.55
Capex 70.55 -2.64 -8.96
Free Cash Flow 79.59 -1.39 -6.80
Revenue 4.02 17.40 16.72
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 4.35 0.11 0.10
Operating Margin 28.45 0.08 0.06
ROA 13.83 < 0.005 < 0.005
ROE 9.79 0.05 0.05
ROIC 48.45 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of XPO is permitted for members.
5 Growth
The "Growth Entry" for the Focus of XPO is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of XPO is permitted for members.